Stocks
Edwards Lifesciences (EW) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 186.8% | 273.8% | 356.9% | 402.5% | 440.3% | ||||
| Changes by years, y/y, % | -84pp | +87pp | -274pp | +46pp | +9.3% | ||||
Edwards Lifesciences. R&D/CAPEX, %
Edwards Lifesciences. R&D/CAPEX, changes, pp
Edwards Lifesciences (EW) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | 2024Q1 | LTM ? | |||
| R&D/CAPEX, % | 488.8% | 265.7% | 436.8% | 334.3% | 440.3% | |||
| Changes by years, y/y, % | +99pp | -261pp | +5pp | +12pp | -90pp | |||
| Changes by quarters, q/q, % | -489pp | +171pp | -102pp | |||||
